Posts tagged: NGS

Whole transcriptome sequencing vs 3′ RNA sequencing: which approach is right for your study?

RNA sequencing (RNA-seq) has become a standard tool for studying gene expression, helping researchers investigate everything from disease mechanisms and drug responses to biomarker discovery and cell biology. However, ...
Continue reading

What is next generation sequencing (NGS)?

Next-generation sequencing (NGS) is a revolutionary genomic sequencing technology that allows researchers to quickly and cost-effectively analyse large quantities of genetic material.
Continue reading

Short-read vs. long-read sequencing: choosing the right approach for your genomic research

Over the last two decades, the world of DNA sequencing has evolved at an astonishing pace. Since the initial human genome project, which took years and billions of dollars to complete, modern instruments now deliver ...
Continue reading

Amoy Diagnostics: strengthening precision oncology through strategic partnership

Amoy Diagnostics (AmoyDx) and Almac Diagnostic Services have developed a partnership over the past five years, significantly advancing the field of precision oncology. This collaboration has led to the development and ...
Continue reading

Long-read sequencing: NGS "method of the year"

Long-read sequencing technologies provide analysis of large and intricate regions of the genome, and recent significant technological advancements in long-read sequencing instruments seem to have reinvigorated interest in this method.
Continue reading

Elacestrant for advanced breast cancer: NICE recommendations and ESR1 testing

The National Institute for Health and Care Excellence (NICE) has issued recommendations for the use of Elacestrant in treating oestrogen receptor-positive (ER+), HER2-negative advanced breast cancer with an ESR1 mutation.
Continue reading